Review highlights ginsenosides' role in targeting autophagy to improve outcomes in ovarian cancer, suggesting new therapies.
This review provides a comprehensive overview of current knowledge regarding autophagy regulation in ovarian cancer, summarizes the structural and pharmacological characteristics of ginsenosides, and discusses their emerging role as autophagy-targeting agents, particularly in the treatment of this malignancy. Collectively, these insights offer a new perspective for the development of autophagy-based precision therapies for ovarian cancer.
No takes yet. Share an insight, caveat, or question.
Guo et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: